Usca Ria LLC lifted its holdings in shares of Walgreens Boots Alliance (NASDAQ:WBA) by 107.1% during the first quarter, HoldingsChannel.com reports. The firm owned 58,485 shares of the pharmacy operator’s stock after acquiring an additional 30,248 shares during the quarter. Usca Ria LLC’s holdings in Walgreens Boots Alliance were worth $3,829,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in WBA. Alpha Omega Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 100.0% during the first quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 800 shares during the period. Financial Advocates Investment Management acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at approximately $125,000. Fieldpoint Private Securities LLC raised its position in Walgreens Boots Alliance by 428.6% in the 4th quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock valued at $134,000 after buying an additional 1,500 shares during the last quarter. QCI Asset Management Inc. NY raised its position in Walgreens Boots Alliance by 95.9% in the 1st quarter. QCI Asset Management Inc. NY now owns 2,155 shares of the pharmacy operator’s stock valued at $141,000 after buying an additional 1,055 shares during the last quarter. Finally, Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 69.1% in the 1st quarter. Reilly Financial Advisors LLC now owns 2,242 shares of the pharmacy operator’s stock valued at $147,000 after buying an additional 916 shares during the last quarter. 61.52% of the stock is currently owned by institutional investors.
Shares of NASDAQ WBA opened at $65.74 on Thursday. The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 12 month low of $64.88 and a 12 month high of $65.72. The company has a market cap of $64.07 billion, a PE ratio of 11.44, a price-to-earnings-growth ratio of 1.05 and a beta of 1.15.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company had revenue of $33.02 billion during the quarter, compared to the consensus estimate of $32.20 billion. During the same period in the previous year, the company posted $1.36 EPS. The firm’s revenue for the quarter was up 12.1% compared to the same quarter last year. research analysts expect that Walgreens Boots Alliance will post 5.92 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.43%. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.
In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total transaction of $179,372.16. Following the completion of the transaction, the director now directly owns 13,679 shares in the company, valued at approximately $896,795.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.80% of the company’s stock.
A number of brokerages recently issued reports on WBA. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Tuesday, May 1st. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Jefferies Group set a $85.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday, April 3rd. Barclays began coverage on Walgreens Boots Alliance in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 target price on the stock. Finally, Bank of America began coverage on Walgreens Boots Alliance in a research report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $83.20.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.